Did you mean 3705 2,3 3?
Displaying drugs 8826 - 8850 of 10965 in total
Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose
Experimental
Matched Name: … Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose …
Matched Iupac: … {[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[( ... 2R,3R,4R,5S,6R)-5-fluoro-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]phosphinic …
Matched Iupac: … {[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[( ... 2R,3R,4R,5S,6R)-5-fluoro-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]phosphinic …
Reproxalap
Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson syndrome. NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.
Investigational
Matched Synonyms: … NS-2 …
Matched Iupac: … 2-(3-amino-6-chloroquinolin-2-yl)propan-2-ol …
Matched Description: … Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics ... [L32990] NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Iupac: … 2-(3-amino-6-chloroquinolin-2-yl)propan-2-ol …
Matched Description: … Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics ... [L32990] NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
D-4-hydroxyphenylglycine
Experimental
Matched Synonyms: … (R)-ethyl 2-amino-2-(4-hydroxyphenyl)acetate ... D-2-amino-2-(p-hydroxyphenyl)acetic acid ... (R)-2-(4-hydroxyphenyl)glycine …
Matched Iupac: … (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid …
Matched Iupac: … (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid …
N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide
Experimental
Matched Iupac: … -2-yl]benzamide ... N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan …
beta-Pinene
Experimental
Matched Synonyms: … 2(10)-pinene …
Matched Iupac: … 6,6-dimethyl-2-methylidenebicyclo[3.1.1]heptane …
Matched Iupac: … 6,6-dimethyl-2-methylidenebicyclo[3.1.1]heptane …
CTS-1027
CTS-1027 has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C Virus Infection.
Experimental
Investigational
Lonigutamab
Lonigutamab is under investigation in clinical trial NCT05683496 (Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)).
Investigational
(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID
Experimental
Matched Iupac: … N-{4-[2-(2-{[(tert-butoxy)carbonyl]amino}ethyl)-3-ethoxy-2-(ethoxycarbonyl)-3-oxopropyl]phenyl}sulfamic …
N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE
Experimental
Matched Name: … N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE …
Matched Iupac: … (1r,4r)-N-{2'-[(4-fluorophenyl)amino]-[4,4'-bipyridin]-2-yl}-4-methoxycyclohexane-1-carboxamide …
Matched Iupac: … (1r,4r)-N-{2'-[(4-fluorophenyl)amino]-[4,4'-bipyridin]-2-yl}-4-methoxycyclohexane-1-carboxamide …
Apomorphine palmitate
Investigational
Matched Iupac: … -hexaen-3-yl hexadecanoate ... (9R)-4-(hexadecanoyloxy)-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2(7),3,5,13,15 …
Pegadricase
Pegadricase is under investigation in clinical trial NCT01021241 (Safety and Efficacy Study of Intravenous Uricase-PEG 20).
Investigational
Sulfamethylthiazole
Experimental
Matched Synonyms: … N(sup 1)-(4-Methyl-2-thiazolyl)sulfanilamide ... 4-Amino-N-(4-methyl-2-thiazolyl)benzenesulfonamide …
Matched Iupac: … 4-amino-N-(4-methyl-1,3-thiazol-2-yl)benzene-1-sulfonamide …
Matched Iupac: … 4-amino-N-(4-methyl-1,3-thiazol-2-yl)benzene-1-sulfonamide …
2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID
Experimental
Matched Name: … 2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID …
Matched Iupac: … 2-[(1E)-2-(4-hydroxyphenyl)diazen-1-yl]benzoic acid …
Matched Iupac: … 2-[(1E)-2-(4-hydroxyphenyl)diazen-1-yl]benzoic acid …
Bifunctional epoxide hydrolase 2
Bifunctional epoxide hydrolase 2 is under investigation in clinical trial NCT00654966 (Evaluation of the Effects of Urotensin-II and Soluble Epoxide Hydrolase Inhibitors on Skin Microvessel Tone in Patients With Heart Failure, and in Healthy Volunteers).
Investigational
Matched Name: … Bifunctional epoxide hydrolase 2 …
Matched Description: … Bifunctional epoxide hydrolase 2 is under investigation in clinical trial NCT00654966 (Evaluation of …
Matched Description: … Bifunctional epoxide hydrolase 2 is under investigation in clinical trial NCT00654966 (Evaluation of …
Rostaporfin
Investigational
Matched Iupac: … -tetramethyl-7,23,24,25-tetraazahexacyclo[18.2.1.1^{5,8}.1^{10,13}.1^{15,18}.0^{2,6}]hexacosa-1(23),2( …
CVnCoV
The CVnCov Vaccine (or CV07050101) is in development by CureVac AG. The vaccine uses mRNA technology to create a protein associated with SARS-CoV2, and upon administration and replication, to initiate subsequent immune responses in the body. As of June 2020, the company received regulatory approval from German and Belgian Authorities...
Investigational
Matched Synonyms: … SARS-CoV-2 mRNA vaccine …
Dotatoc gallium Ga-68
Investigational
Matched Iupac: … (68Ga)gallium(3+) 2-[4-({[(1R)-1-{[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-{[(2R,3R)-1,3-dihydroxybutan ... -2-yl]carbamoyl}-7-[(1R)-1-hydroxyethyl]-13-[(1H-indol-3-yl)methyl]-16-[(naphthalen-1-yl)methyl]-6,9,12,15,18 ... -pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl]carbamoyl}-2-phenylethyl]carbamoyl}methyl …
N-(2-Acetamido)Iminodiacetic Acid
Experimental
Matched Name: … N-(2-Acetamido)Iminodiacetic Acid …
Matched Iupac: … 2-[(carbamoylmethyl)(carboxymethyl)amino]acetic acid …
Matched Iupac: … 2-[(carbamoylmethyl)(carboxymethyl)amino]acetic acid …
2-Cyclopropylmethylenepropanal
Experimental
Matched Name: … 2-Cyclopropylmethylenepropanal …
Matched Iupac: … (2S)-3-cyclopropyl-2-methylpropanal …
Matched Iupac: … (2S)-3-cyclopropyl-2-methylpropanal …
Sirexatamab
Investigational
N-cyclohexyltaurine
Experimental
Matched Synonyms: … 2-(cyclohexylamino)ethanesulfonic acid …
Matched Iupac: … 2-(cyclohexylamino)ethane-1-sulfonic acid …
Matched Iupac: … 2-(cyclohexylamino)ethane-1-sulfonic acid …
Idrocilamide
Experimental
Matched Synonyms: … N-(2-hydroxyethyl)cinnamamide …
Matched Iupac: … (2E)-N-(2-hydroxyethyl)-3-phenylprop-2-enamide …
Matched Iupac: … (2E)-N-(2-hydroxyethyl)-3-phenylprop-2-enamide …
Efprezimod alfa
CD24Fc is a biological immunomodulator originally developed to address graft-versus-host disease in stem cell transplantation in leukemia patients.
Investigational
3,4-Methylenedioxy-N-isopropylamphetamine
MDI-P has demonstrated potent anti-HIV activity. MDI-P has been shown to be effective in killing HIV in cell culture. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). MDI-P is also a potential therapeutic agent for the treatment of the symptoms of cystic fibrosis ("CF").
Investigational
Matched Iupac: … [1-(2H-1,3-benzodioxol-5-yl)propan-2-yl](propan-2-yl)amine …
6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide
Experimental
Matched Name: … 6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide …
Matched Iupac: … N-[4-(aminomethyl)phenyl]-6-carbamimidoyl-4-[(pyrimidin-2-yl)amino]naphthalene-2-carboxamide …
Matched Iupac: … N-[4-(aminomethyl)phenyl]-6-carbamimidoyl-4-[(pyrimidin-2-yl)amino]naphthalene-2-carboxamide …
Displaying drugs 8826 - 8850 of 10965 in total